, Tracking Stock Market Picks
Enter Symbol:
Geron Corporation (GERN) [hlAlert]

down 54.43 %

Geron Corporation (GERN) upgraded to Buy by Merriman

Posted on: Monday,  Oct 19, 2009  8:25 AM ET by Merriman

Merriman rated Buy Geron Corporation (NASDAQ: GERN) on 10/19/2009, when the stock price was $6.76. Since
then, Geron Corporation has lost 54.44% as of 01/25/2016's recent price of $3.08.
If you would have followed this Merriman's recommendation on GERN, you would have lost 54.43% of your investment in 2289 days.

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/19/2009 8:25 AM Buy
as of 12/31/2009
1 Week down  -18.21 %
1 Month down  -8.28 %
3 Months down  -29.58 %
1 YTD down  -29.58 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/23/2009 8:55 PM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy